Biologics Hospitals Spine Congress should hold oversight hearings to ensure FDA prioritizes safety for biosimilars byJosh SandbergMay 6, 2015
Hospitals Spine Congress Should Hold Oversight Hearings to Ensure FDA Prioritizes Safety for Biosimilars | Commentary byJosh SandbergApril 29, 2015
Hospitals Spine UNITED SPINAL URGES CONGRESS TO HOLD OVERSIGHT HEARINGS ON BIOSIMILAR MEDICINES TO ENSURE FDA PRIORITIZES SAFETY byJosh SandbergApril 17, 2015
